UMIN ID: C000000202
Registered date:13/09/2005
Therapeutic Efficacy of an Angiotensin II Receptor Antagonist in Patients with Nonalcoholic Steathepatitis
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Nonalcoholic steatohepatitis |
| Date of first enrollment | 2004/11/01 |
| Target sample size | 10 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Angiotensin II receptor Antagonist 1 or 2 tablets per day for at least 48 weeks |
Outcome(s)
| Primary Outcome | transaminase |
|---|---|
| Secondary Outcome | insulin resistance liver histology |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Allergy to Angiotensin II receptor Antagonist(ARB) complication with liver diseases due to other causes secondary NASH medication history of ARB or ACE inhibitors |
Related Information
| Primary Sponsor | Gunma Liver Study Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Gunma Liver Study Group |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Ken Sato |
| Address | 3-39-22 Showa, Maebashi, Gunma 371-8511, Japan. Japan |
| Telephone | 027-220-8127 |
| satoken@gunma-u.ac.jp | |
| Affiliation | Gunma University Graduate School of Medicine Department of Medicine and Molecular Science |
| scientific contact | |
| Name | Ken Sato |
| Address | 3-39-22 Showa, Maebashi, Gunma 371-8511, Japan. Japan |
| Telephone | 027-220-8127 |
| satoken@gunma-u.ac.jp | |
| Affiliation | Gunma University Graduate School of Medicine Department of Medicine and Molecular Science |